Logo image of BTTX

BETTER THERAPEUTICS INC (BTTX) Stock Analyst Ratings

NASDAQ:BTTX - Nasdaq - US08773T1043 - Common Stock - Currency: USD

0.0446  +0.01 (+27.43%)

After market: 0.036 -0.01 (-19.28%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to BTTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.36. This target is 11906.73% above the current price.
BTTX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BTTX.
In the previous month the buy percentage consensus was at a similar level.
BTTX was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

BTTX Historical Analyst RatingsBTTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.041.525.365.369.45 - 3,296.86% 11,906.73% 11,906.73% 21,088.34%

Related screens

BTTX Current Analyst RatingBTTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2023-08-10 Chardan Capital Reiterate Buy -> Buy
2023-08-10 Lake Street Maintains Buy -> Buy
2023-04-14 Lake Street Maintains Buy
2023-03-31 Chardan Capital Maintains Buy
2022-11-15 Chardan Capital Maintains Buy
2022-07-29 Chardan Capital Maintains Buy
2021-11-24 Chardan Capital Initiate Buy
2021-11-10 Cowen & Co. Initiate Outperform